Ecuador authorises Wandercraft Atalante X for clinical rehabilitation - 2026-07-27 - Regulatory - The authorised uses cover rehabilitation associated with spinal-cord injury, stroke-related hemiplegia and multiple sclerosis. Clínica de Lesiones Deportivas in Quito is the first announced Ecuador installation site. The clinic… - source: clinicadelesionesdeportivas.com
Wandercraft's Atalante X receives second FDA clearance - 2024-02-13 - Regulatory - Wandercraft received FDA clearance for Atalante X for rehabilitation in individuals with spinal cord injuries at levels T5 to L5. This follows the device's previous clearance for stroke rehabilitation in December 2022. The clearance… - source: wandercraft.eu
Wandercraft receives EUR 25M EIB loan - 2023-12-28 - Market Signal - The EIB loan supports development of Wandercraft’s personal exoskeleton and broader access to Atalante X. The financing benefits from an InvestEU guarantee. The EUR 25 million facility was structured as an EIB venture-debt loan. - source: eib.org